Substance Use Disorder is associated with the increased risk and severity of numerous infections in addition to immune dysregulation that can contribute to cardiovascular, kidney, liver, and autoimmune diseases. A better understanding of the intersection of addiction, infection, and immunology can develop strategies to prevent and treat substance use disorder and diminish sequelae.
Ongoing Studies
Addiction, Infection, and Immunology Research Program
(MPI: Drs. Ellen Eaton and James Kobie; Funding UAB HSF-GEF)
The AIIRP will leverage the unique addiction-impacted populations of AL, the vast addiction-related clinical and research capabilities of UAB, and its large and reputable excellence in infection and immunology research to promote collaborations and develop new external research funding streams. This population-centered research program will galvanize the infrastructure to support and foster this multi-disciplinary research through establishment of on-demand patient sampling infrastructure, defining the immune/infection profile of individuals that inject fentanyl and methamphetamine, and building the AIIRP research community.
Learn more about Ellen EatonLearn more about James KobieConnect with the AIIRP